Conversely, in diabetic nephropathy, TET2 acts as a regulator of TGF-β1 by initiating the process of demethylation at the TGF-β1 regulatory regions and increasing its expression [44]. This evidence concerns the gene TGFB1 and diabetic kidney disease.